Centogene NV
NASDAQ:CNTG
Centogene NV
NASDAQ:CNTG
Price:
0.4889 USD
1.88%
Market Closed
Updated:
Apr 29, 2024
Centogene NV
Cash from Financing Activities
|
Centogene NV
Cash from Financing Activities Peer Comparison
Comparables:
BNTX
MOR
IMTX
BIO
FYB
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Centogene NV
NASDAQ:CNTG
|
Cash from Financing Activities
€46.3m
|
CAGR 3-Years
22%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Cash from Financing Activities
-€778.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MorphoSys AG
XETRA:MOR
|
Cash from Financing Activities
€43m
|
CAGR 3-Years
-64%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-11%
|
|
|
Immatics NV
NASDAQ:IMTX
|
Cash from Financing Activities
€84.5m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Biotest AG
XETRA:BIO
|
Cash from Financing Activities
-€6.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
Formycon AG
XETRA:FYB
|
Cash from Financing Activities
€40.7m
|
CAGR 3-Years
33%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
See Also
What is Centogene NV's Cash from Financing Activities?
Cash from Financing Activities
46.3m
EUR
46.3m
EUR
Based on the financial report for Dec 31, 2022, Centogene NV's Cash from Financing Activities amounts to 46.3m EUR.
What is Centogene NV's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
21%
21%
The average annual Cash from Financing Activities growth rates for Centogene NV have been 22% over the past three years , 21% over the past five years .
You don't have any saved screeners yet
